J&J Baby-Powder Asbestos Cover-Up (1970s–2020s)
Introduction
Johnson & Johnson''s baby powder — one of the most recognised consumer products in the world — has been at the centre of a decades-long legal and public health controversy over asbestos contamination of cosmetic talc. A December 2018 Reuters investigation, drawing on thousands of pages of internal J&J documents, found that the company had known for decades that its talc could contain asbestos and had not disclosed this information to regulators or the public.
What the Internal Documents Show
The Reuters investigation reviewed J&J internal memos, studies, and correspondence dating from the 1970s through the early 2000s. Key findings included:
- Internal tests commissioned by J&J and its suppliers found trace amounts of asbestos in talc samples from the 1970s onward.
- Some documents showed J&J scientists and executives discussing the asbestos findings and the regulatory risk they posed.
- The company lobbied regulators — including the FDA — to adopt testing standards that were less sensitive to asbestos detection.
- J&J communicated to regulators that its talc was asbestos-free while internal records showed testing that found otherwise.
J&J disputed the Reuters interpretation of the documents, arguing the findings were isolated and that the overwhelming weight of evidence showed its talc was safe.
Litigation and the Ingham Verdict
By 2018, thousands of lawsuits had been filed by plaintiffs alleging that asbestos-contaminated J&J baby powder caused their ovarian cancer or mesothelioma (a cancer directly linked to asbestos exposure). The most significant single verdict came in July 2018 in Ingham v. Johnson & Johnson, a Missouri state court case brought by 22 women. The jury awarded $4.69 billion in damages — $550 million compensatory, $4.14 billion punitive. J&J appealed; the Missouri Court of Appeals reduced the award to $2.1 billion in 2021. J&J continued to appeal to the US Supreme Court.
Product Discontinuation
In May 2020, J&J announced it would discontinue talc-based baby powder sales in the United States and Canada, citing "misinformation" and "a constant barrage of litigation advertising." In August 2023, J&J announced global discontinuation of talc-based baby powder, replacing it with a cornstarch-based formula. The company maintained that the product was safe and that the discontinuation was a business decision.
The LTL Bankruptcy Strategy
J&J attempted to resolve its talc liability by creating a subsidiary — LTL Management — and placing it into Chapter 11 bankruptcy, a strategy that would have channelled all talc claims into a bankruptcy trust and capped J&J''s liability. The "Texas Two-Step" bankruptcy manoeuvre was rejected twice by federal courts. In January 2023, the Third Circuit Court of Appeals ruled that LTL was not in financial distress sufficient to justify bankruptcy and dismissed the case. A second bankruptcy filing was also rejected in 2023.
Verdict
Confirmed. The Reuters investigation, internal documents, the Ingham verdict, and J&J''s own decision to discontinue the product globally confirm that the company had internal knowledge of asbestos contamination that was not adequately disclosed to regulators or consumers. The scale of litigation — tens of thousands of cases — and the judicial rejection of the bankruptcy strategy confirm the legal and factual foundation of the concealment claim.
Evidence Filters11
Reuters December 2018: internal documents showing asbestos knowledge
SupportingStrongThe Reuters investigation published internal J&J documents from the 1970s onward showing that company-commissioned tests and supplier tests found asbestos in talc samples, and that executives and scientists were aware of and discussed this contamination.
Ingham v. J&J (2018): $4.69 billion jury verdict
SupportingStrongA Missouri state jury awarded $4.69 billion to 22 women who alleged asbestos-contaminated J&J talc caused their ovarian cancer — $550 million compensatory and $4.14 billion punitive. The Missouri Court of Appeals reduced the verdict to $2.1 billion in 2021.
US/Canada baby powder discontinued 2020; global 2023
SupportingStrongJ&J announced discontinuation of talc-based baby powder in the US and Canada in May 2020, citing "misinformation" and litigation pressure. Global discontinuation followed in August 2023. The company denies safety problems but no longer markets the product.
LTL bankruptcy strategy rejected twice by federal courts (2023)
SupportingJ&J's "Texas Two-Step" strategy of transferring talc liability to subsidiary LTL Management and placing it in Chapter 11 bankruptcy was rejected by the Third Circuit Court of Appeals in January 2023 and a subsequent filing was also dismissed. Federal courts found LTL was not in genuine financial distress.
J&J lobbied for less-sensitive asbestos testing standards
SupportingStrongInternal documents showed J&J lobbied the FDA and industry bodies to adopt talc testing methodologies that were less sensitive to asbestos detection than alternatives available to regulators. This lobbying occurred while the company was representing its talc as asbestos-free.
Tens of thousands of active cases — ovarian cancer and mesothelioma
SupportingBy 2023, tens of thousands of lawsuits had been filed by plaintiffs alleging talc-related ovarian cancer and mesothelioma — a form of cancer with an exceptionally strong causal link to asbestos exposure. The volume and medical specificity of the claims corroborate the asbestos contamination evidence.
J&J disputes Reuters interpretation and maintains product safety
DebunkingJ&J has consistently disputed the Reuters investigation's conclusions, arguing that the cited internal tests were isolated incidents and that the overwhelming body of evidence showed its talc was asbestos-free and safe. The company has pointed to FDA tests that found no asbestos in J&J talc samples.
Rebuttal
The dispute over individual test results does not undermine the core finding that positive internal tests were not disclosed to regulators. The volume of litigation and the scale of jury verdicts indicate that courts have not accepted J&J's characterisation as fully exculpatory.
FDA conducted some tests finding no asbestos in J&J talc
DebunkingSome FDA-conducted tests of J&J talc over the years found no asbestos contamination. J&J has cited these results as evidence of the product's safety. The dispute over testing methodology and sample selection is genuine.
Rebuttal
Negative tests in some samples do not establish that all samples were clean, particularly given internal J&J documents showing positive results in others. The testing methodology dispute is real but does not resolve the disclosure question.
Internal J&J Documents Show Decades of Asbestos Detection
SupportingStrongReuters' 2018 investigation citing internal J&J memos and test results dating to the 1970s showed company scientists detected asbestos in talc samples on multiple occasions. Executives discussed how to address regulatory scrutiny without triggering product withdrawal or public disclosure.
FDA Testing Found Asbestos in Baby Powder Samples (2019)
SupportingStrongIn October 2019 the FDA announced its own laboratory testing had detected chrysotile asbestos in a single Johnson's Baby Powder bottle from an online retailer. J&J disputed the methodology, but the finding prompted a voluntary recall of 33,000 bottles and intensified litigation.
Show 1 more evidence point
Many Individual Lawsuits Failed to Prove Causation
DebunkingDespite thousands of lawsuits, courts including the US Third Circuit repeatedly found insufficient epidemiological evidence linking cosmetic talc specifically to ovarian cancer in individual plaintiffs. The International Agency for Research on Cancer classifies perineal talc use as only a Group 2B 'possible carcinogen' — a relatively weak designation.
Evidence Cited by Believers8
Reuters December 2018: internal documents showing asbestos knowledge
SupportingStrongThe Reuters investigation published internal J&J documents from the 1970s onward showing that company-commissioned tests and supplier tests found asbestos in talc samples, and that executives and scientists were aware of and discussed this contamination.
Ingham v. J&J (2018): $4.69 billion jury verdict
SupportingStrongA Missouri state jury awarded $4.69 billion to 22 women who alleged asbestos-contaminated J&J talc caused their ovarian cancer — $550 million compensatory and $4.14 billion punitive. The Missouri Court of Appeals reduced the verdict to $2.1 billion in 2021.
US/Canada baby powder discontinued 2020; global 2023
SupportingStrongJ&J announced discontinuation of talc-based baby powder in the US and Canada in May 2020, citing "misinformation" and litigation pressure. Global discontinuation followed in August 2023. The company denies safety problems but no longer markets the product.
LTL bankruptcy strategy rejected twice by federal courts (2023)
SupportingJ&J's "Texas Two-Step" strategy of transferring talc liability to subsidiary LTL Management and placing it in Chapter 11 bankruptcy was rejected by the Third Circuit Court of Appeals in January 2023 and a subsequent filing was also dismissed. Federal courts found LTL was not in genuine financial distress.
J&J lobbied for less-sensitive asbestos testing standards
SupportingStrongInternal documents showed J&J lobbied the FDA and industry bodies to adopt talc testing methodologies that were less sensitive to asbestos detection than alternatives available to regulators. This lobbying occurred while the company was representing its talc as asbestos-free.
Tens of thousands of active cases — ovarian cancer and mesothelioma
SupportingBy 2023, tens of thousands of lawsuits had been filed by plaintiffs alleging talc-related ovarian cancer and mesothelioma — a form of cancer with an exceptionally strong causal link to asbestos exposure. The volume and medical specificity of the claims corroborate the asbestos contamination evidence.
Internal J&J Documents Show Decades of Asbestos Detection
SupportingStrongReuters' 2018 investigation citing internal J&J memos and test results dating to the 1970s showed company scientists detected asbestos in talc samples on multiple occasions. Executives discussed how to address regulatory scrutiny without triggering product withdrawal or public disclosure.
FDA Testing Found Asbestos in Baby Powder Samples (2019)
SupportingStrongIn October 2019 the FDA announced its own laboratory testing had detected chrysotile asbestos in a single Johnson's Baby Powder bottle from an online retailer. J&J disputed the methodology, but the finding prompted a voluntary recall of 33,000 bottles and intensified litigation.
Counter-Evidence3
J&J disputes Reuters interpretation and maintains product safety
DebunkingJ&J has consistently disputed the Reuters investigation's conclusions, arguing that the cited internal tests were isolated incidents and that the overwhelming body of evidence showed its talc was asbestos-free and safe. The company has pointed to FDA tests that found no asbestos in J&J talc samples.
Rebuttal
The dispute over individual test results does not undermine the core finding that positive internal tests were not disclosed to regulators. The volume of litigation and the scale of jury verdicts indicate that courts have not accepted J&J's characterisation as fully exculpatory.
FDA conducted some tests finding no asbestos in J&J talc
DebunkingSome FDA-conducted tests of J&J talc over the years found no asbestos contamination. J&J has cited these results as evidence of the product's safety. The dispute over testing methodology and sample selection is genuine.
Rebuttal
Negative tests in some samples do not establish that all samples were clean, particularly given internal J&J documents showing positive results in others. The testing methodology dispute is real but does not resolve the disclosure question.
Many Individual Lawsuits Failed to Prove Causation
DebunkingDespite thousands of lawsuits, courts including the US Third Circuit repeatedly found insufficient epidemiological evidence linking cosmetic talc specifically to ovarian cancer in individual plaintiffs. The International Agency for Research on Cancer classifies perineal talc use as only a Group 2B 'possible carcinogen' — a relatively weak designation.
Timeline
Ingham verdict: Missouri jury awards $4.69 billion
A Missouri jury awards $4.69 billion to 22 women who alleged asbestos-contaminated J&J talc caused their ovarian cancer. The punitive component — $4.14 billion — reflects the jury's finding of deliberate concealment. The verdict is the largest in the talc litigation.
Source →Reuters investigation: J&J knew of asbestos contamination for decades
Reuters publishes its investigation of internal J&J documents showing that the company commissioned tests found asbestos in talc from the 1970s onward and that executives discussed the regulatory risk. J&J's stock falls approximately 10% on the day of publication.
Source →Reuters Investigation Publishes Internal J&J Asbestos Memos
Reuters published a landmark investigation using internal company documents, scientific studies, and trial exhibits showing J&J had known since at least 1971 that its talc occasionally tested positive for asbestos. The story triggered a 10% stock drop and a wave of new litigation filings.
Source →J&J discontinues talc baby powder in US and Canada
J&J announces discontinuation of talc-based baby powder in the US and Canada, citing litigation and "misinformation." Global discontinuation follows in August 2023. The company replaces the product with a cornstarch-based formula.
Verdict
Reuters December 2018 investigation of internal J&J documents confirmed decades of internal knowledge of asbestos in talc without adequate regulatory disclosure. Ingham v. J&J (2018): $4.69 billion jury verdict for 22 women with ovarian cancer (reduced to $2.1 billion on appeal). J&J discontinued US/Canadian talc baby powder in 2020 and global sales in 2023. Two attempts to resolve liability via LTL Management bankruptcy rejected by federal courts in 2023. Tens of thousands of active cases remain.
Frequently Asked Questions
How long did J&J know about potential asbestos contamination?
The Reuters December 2018 investigation found internal J&J documents dating from the 1970s onward showing company-commissioned and supplier tests found trace amounts of asbestos in talc samples. If the Reuters interpretation of the documents is accurate, J&J had internal awareness for approximately 40 to 50 years before the global product discontinuation in 2023.
What cancers are linked to asbestos-contaminated talc?
Plaintiffs in talc litigation have primarily alleged two cancers: ovarian cancer (the claim in the Ingham and related cases) and mesothelioma. Mesothelioma has a well-established and extremely strong causal link to asbestos exposure. The link between talc and ovarian cancer has been more scientifically contested, though thousands of plaintiffs have prevailed in litigation.
What was the LTL bankruptcy strategy and why was it rejected?
J&J created a subsidiary called LTL Management, transferred its talc liability to it, and placed LTL in Chapter 11 bankruptcy — a tactic known as the "Texas Two-Step." The strategy would have channelled all talc claims into a bankruptcy trust, capping J&J's liability. The Third Circuit Court of Appeals rejected the strategy twice in 2023, ruling that LTL was not in genuine financial distress sufficient to justify bankruptcy protection.
Is J&J's talc baby powder still sold?
No. J&J discontinued talc-based baby powder in the United States and Canada in May 2020 and globally in August 2023. The product was replaced with a cornstarch-based formula. J&J maintained throughout that the talc product was safe and that the discontinuation was a business decision, not an admission of safety problems.
Sources
Show 6 more sources
Further Reading
- articleReuters investigation: J&J baby powder and asbestos — Lisa Girion (2018)
- paperIngham v. Johnson & Johnson — Missouri Court of Appeals opinion — Missouri Court of Appeals (2021)
- paperAsbestos and mesothelioma: clinical and legal overview — JAMA editorial board (2020)
- bookSpillover: The Gripping Story of the World's Most Dangerous Viruses — Parallel Corporate Concealment Analysis — David Quammen (2012)